There has been an increasing awareness of the importance of differentiating NF1 and NF2 in recent years culminating in the mapping of the genes to different chromosomes"q in 1987. In the same year the NIH Consensus Conference statement defined diagnostic criteria for NF1 and NF2.5 The NF2 criteria include distinct ophthalmological findings (posterior subcapsular lenticular opacities), although the frequency of these had been assessed in relatively small numbers of patients at that time.6 The NIH criteria for NFl have been used in a large study and found to be satisfactory,7 but the NF2 criteria have not been similarly assessed.
Abstract
The major defining features, age at onset of symptoms, and survival in 150 patients with type 2 neurofibromatosis (NF2) have been studied. The mean age at onset was 21-57 years (n=110) and no cases presented after 55 years of age. Patients presented with symptoms attributable to vestibular schwannomas (acoustic neuroma), cranial meningiomas, and spinal tumours. In 97 cases studied personally by the authors, skin and eye examination were found to be useful to detect early signs of the condition. Examination of the skin is likely to assist in early diagnosis in at least 10% of cases and examination of the eye for a lens opacity or cataract in at least as many again. There are marked interfamilial differences in disease severity and tumour susceptibility. Vestibular schwannomas are not fully penetrant, but the condition is usually expressed in another way. Alteration to the current diagnostic criteria is advocated to cover the lack of provision for new mutations. A screening protocol is proposed and the effect of disease heterogeneity on management is discussed.
(J Med Genet 1992;29: There has been an increasing awareness of the importance of differentiating NF1 and NF2 in recent years culminating in the mapping of the genes to different chromosomes"q in 1987. In the same year the NIH Consensus Conference statement defined diagnostic criteria for NF1 and NF2.5 The NF2 criteria include distinct ophthalmological findings (posterior subcapsular lenticular opacities), although the frequency of these had been assessed in relatively small numbers of patients at that time. 6 The NIH criteria for NFl have been used in a large study and found to be satisfactory,7 but the NF2 criteria have not been similarly assessed.
A large clinical and genetic study of NF2 has allowed us to address these and other issues. The study has highlighted the inadequacy of current counselling and screening of at risk relatives. In this paper we present the findings of the study with relevance to genetic counselling, namely, the adequacy of current diagnostic criteria, the natural history of NF2, and suggestion of a screening protocol for at risk subjects.
Patients and methods
The methods of patient ascertainment, clinical assessment, and diagnostic criteria are described in the preceding paper.8 In addition all cases who did not precisely fit the NIH NF2 criteria (table 1) , but who were thought to have the disease on clinical grounds were studied to allow evaluation of the diagnostic criteria.
Results
One hundred and fifty-five cases were entered into the study. After using additional criteria ( Four of the 97 patients examined had noticed skin lumps as a prominent feature before any other symptom and three of these had them removed with a histological diagnosis of neurofibroma or schwannoma. Four out of the six patients remaining asymptomatic, but who had been diagnosed on scan as having acoustic tumours, had easily identifiable skin lumps. A further two cases, aged 27 and 52 respectively, who had a diagnosis of NF2 on the basis of a family history of NF2 plus meningiomas and spinal tumours, but who as yet had not developed vestibular schwannomas, had three and six skin tumours respectively. Therefore, in a total of 10/97 cases skin examination would have aided early diagnosis.
Overlap with NFI Only one patient in this series if seen in isolation could have fulfilled the diagnostic criteria for NF1 (table 3) . This was the patient with six cafe au lait patches who also had two discrete skin tumours, although these were of the NF2 plaque type. The skin tumours in NF2 are far less numerous and usually clinically different from those occurring in NF1. Those There were two sporadic cases with unilateral vestibular schwannoma plus three and four cranial meningiomas at the ages of 46 and 53 years respectively. Finally, a mother and son with multiple meningiomas and skin tumours, but no cafe au lait patches, died at the ages of 31 and 16 years, respectively, without vestibular schwannoma.
MORBIDITY AND MORTALITY
The average age at onset of symptoms in 110 cases in the UK was 21-57 years and at diagnosis 27-55 years. Mean age at death in 40 cases was 36-25 years, but including the living cases mean actuarial survival was 62 years. Age (years) Figure 2 Cumulative incidence of 120 cases with NF2.
Mean actuarial survival from diagnosis was 15 years. In the North West region where there were 19 living cases, mean age at onset was 26-5 years and at diagnosis 305 years, showing that ascertainment bias was not causing identification of only severely affected cases from the remainder of the UK.
AGE AT ONSET CURVE
An age at onset of symptoms curve for 120 people with NF2 is shown in fig 2. EXPERIENCE OF THE FAMILIES Many of the families had little or no understanding of their condition though 11/19 cases in the North West region had been referred for formal genetic counselling before the study; this compared to 33/91 in the rest of the UK. Of those families not formally counselled, very few subjects had heard of neurofibromatosis or NF2. There was some degree of confusion with NF1 in those that had heard of neurofibromatosis, but this did not seem to be a confounding factor as these subjects knew it was the vestibular schwannomas that would be inherited. Many persons were completely unaware of the hereditary nature of the condition. Some form of screening of family members had been adopted in 43/75 families. This was comprehensive in 21/75, in that annual to two yearly scans or brain stem evoked responses were offered to all those at 50% risk. This was reflected in the diagnosis of 11/110 (10%) of the cases asymptomatically. One of these cases had been shown to have abnormal brain stem evoked responses for two years with a normal CT scan and it was only when an MRI scan was performed that his acoustic tumour was visualised. Another case with abnormal audiology also had a negative CT scan before confirmation with MRI. Two subjects were diagnosed as a result of the study, but a further four cases with cataract at 50% risk may well go on to satisfy the criteria.
There was no clear evidence of a worsening of the disease during or just after pregnancy. One case had some transient tinnitus during pregnancy and another presented soon after pregnancy with deafness and tinnitus. Neither case had any serious sequelae and no intervention, surgical or otherwise, was required.
Discussion
This study has confirmed that the clinical presentation and natural history of NF2 is distinct from NFl. The main differences are the relative lack of peripheral features in NF2 and the fact that virtually all gene carriers develop tumours of the nervous system which carry significant morbidity and mortality. Finally, in NF2 severe disease features are limited to the nervous system in contrast to NF1 where complications can occur in almost any body system.6 Our study found no overlap with NF1 complications apart from nervous system tumours. The experience of the families in this study suggests there is a need for 849 ( group.bmj.com on June 19, 2017 -Published by http://jmg.bmj.com/ Downloaded from improving diagnostic awareness of NF2 and screening programmes for at risk relatives. The data presented here should help in achieving this goal.
In terms of diagnosis one of the main problems in the past has been the lumping together of cases with NF2 and NFl. For example, the study of Crowe et all" in 1956 concluded that 5% of subjects with NF1 have vestibular schwannomas. In retrospect, from the published clinical details it is clear these subjects had NF2. More recent studies, which clearly distinguish NF1 and NF2, have not shown an increased incidence of vestibular schwannomas in NF1 patients.612
Our study has shown that overlap in the clinical features of NF1 and NF2 rarely presents a diagnostic problem. In the 97 personally examined cases only one subject, whose mother had bilateral vestibular schwannomas, had six cafe au lait patches and two skin tumours (NF2 plaque type) on skin examination with asymptomatic bilateral vestibular schwannomas on MRI scan. With no family history and on examination by someone unaware of the different types of skin tumours, she could easily have been diagnosed as having NFl. There available were schwannomas rather than neurofibromas and this again may be a way of distinguishing between the rare cases that manifest the criteria for NFI and NF2. Detailed eye examination is probably even more useful for early diagnosis, especially if a slit lamp examination is performed. The association between posterior subcapsular lens opacity and NF2 is only a recent finding. '7 However, cataract has been noted to occur in cases as early as 1937.18 Unfortunately, not all the patients personally examined in this study have had a slit lamp examination, although over 30% had a lens opacity identifiable on ophthalmoscopy alone. The cataracts can be present at a very early age and may well be congenital. These earlier cataracts are polar rather than posterior subcapsular.
Other reports suggest that lens opacity may be present in up to 80% of NF2 cases7 if slit lamp examination is performed. Cataracts had been identified as the first manifestation in 10% of our cases; therefore, a detailed ophthalmological examination of asymptomatic at risk subjects will show signs in a much greater proportion. There is also a strong case for examination of at risk neonates for congenital cataract, as if this is not identified, unilateral blindness is the likely sequel. No patient in this study had more than one Lisch nodule, which is probably within normal limits.'0 There has been one report of multiple Lisch nodules in a patient with NF2,'9 but our report does not support a suggestion that they are a feature of NF2 and we believe they are a useful distinguishing feature between the two types of NF. Retinal hamartomata have also been reported in NF220 and although none was found in this study, they may be a rare feature of the condition.
HETEROGENEITY
The NIH diagnostic criteria for NF2 ( 22 However, in patients presenting at a younger age with multiple, rapidly growing tumours a more aggressive approach is warranted. A cervical spine MRI scan is recommended in all cases before surgery, to avoid perioperative problems from asymptomatic cervical cord tumours. There is no convincing evidence that pregnancy worsens tumours already present in an NF2 case. Indeed the only report to show worsening of vestibular schwannoma in pregnancy23 showed no deterioration in the only NF2 patient over several pregnancies. Nevertheless, women with NF2 must be advised some caution before embarking on a pregnancy.
GENETIC COUNSELLING AND SCREENING
This study has shown a considerable delay between age of first symptom and diagnosis in NF2. Even in some at risk subjects the relevance of peripheral nerve tumours or congenital cataracts had not been appreciated. Only a minority of families had received adequate counselling and screening. The age at onset curve presented in fig 2 will aid genetic counselling. For example, for an asymptomatic at risk subject at 20 years of age their risk before screening of having inherited NF2 will have dropped to 25%. As more families are followed prospectively a curve for age at diagnosis, with screening, will become available.
A protocol for screening subjects at risk of NF2 is shown in fig 3. The early age at onset with 10% of cases symptomatic before 10 years of age warrants earlier screening than generally suggested. The presence of congenital or very early cataracts necessitates detailed early ophthalmological screening and slit lamp evaluation should be used in addition to ophthalmoscopy at least every five years. Screening for vestibular schwannomas should begin in the early teens and brain stem evoked responses (BSER) should be performed annually. BSERs have been shown to be more useful in screening for vestibular schwannomas in NF2 than other audiological tests24; in at least two of our cases BSERs identified a vestibular schwannoma up to two years before a CT scan. Cranial imaging should be reserved for when an abnormality is detected on clinical or audiological examination and for counselling purposes. MRI scans are the imaging technique of choice, because they detect smaller tumours than CT and avoid the risk of radiation. A normal MRI scan at 16 to 18 years will approximately halve the risk of having inherited NF2 and will facilitate reproductive decision making. A normal scan at 30 years will make inheritance very unlikely except in late onset families and could lead to cessation of formal screening. Where onset has been late screening should be continued appropriately. With the mapping and then cloning of the gene, mutation studies will greatly enhance our knowledge of the condition and ability to counsel at risk subjects. Initially linkage studies will be an adjunct to the screening programme allowing cessation of testing at an earlier age in some cases. Eventually, however, some subjects will be able to be completely reassured if they are shown not to have inherited the family mutation in the NF2 gene and screening can be concentrated on asymptomatic high risk cases.
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